Showing results (31-40 of 104) with videos related to
Sort By:
Pageof 11
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 11, 2019
Is the rate of virological failure to cART continuing to decline in recent calendar years?Stefano Rusconi, Maria M Santoro, Nicola Gianotti, et al.The Lancet. HIV|October 2, 2015
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort studyCristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.Medicine|September 8, 2016
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation CohortNicola Squillace, Laura Galli, Alessandra Bandera, et al.BMC Infectious Diseases|December 22, 2018
Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational studyAnna Maria Peri, Davide Paolo Bernasconi, Nadia Galizzi, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013Antonella d'Arminio Monforte, Laura Galli, Sergio Lo Caputo, et al.AIDS Research and Treatment|September 8, 2012
Virological Response in Cerebrospinal Fluid to Antiretroviral Therapy in a Large Italian Cohort of HIV-Infected Patients with Neurological DisordersMaria Letizia Giancola, Patrizia Lorenzini, Antonella Cingolani, et al.Antiviral Therapy|October 1, 2004
Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomesAndrea De Luca, Marilena Vendittelli, Francesco Baldini, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2020
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohortsRoberto Rossotti, Alessandro Tavelli, Stefano Bonora, et al.Medicina (Kaunas, Lithuania)|February 26, 2025
Prognostic Value of Procalcitonin in Febrile People Living with Human Immunodeficiency Virus (PLWH) Admitted to the Emergency DepartmentLuigi Celani, Luigi Carbone, Francesco Ceppa, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2021
Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA CohortAndrea Giacomelli, Alessandro Cozzi-Lepri, Antonella Cingolani, et al.Pageof 11